华东医药：上半年净利润同比增长7.01% 拟10派3.5元

Core Insights - Company reported a revenue of 21.675 billion with a year-on-year growth of 3.39% [1] - Net profit attributable to shareholders reached 1.815 billion, reflecting a year-on-year increase of 7.01% [1] - Basic earnings per share stood at 1.03 yuan [1] Financial Performance - The company plans to distribute a cash dividend of 3.5 yuan per 10 shares (tax included) [1] - Revenue from sales and agency services amounted to 1.084 billion, with a significant year-on-year growth of 59% [1] - The company is benefiting from the approval and launch of new products, contributing to the growth in innovative product revenue [1]